Literature DB >> 16476888

Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography.

Annie Chan1, Jay S Duker, Tony H Ko, James G Fujimoto, Joel S Schuman.   

Abstract

OBJECTIVE: To report normal macular thickness measurements in healthy eyes using the latest commercially available optical coherence tomography (OCT) mapping software, version 3.0, from the Stratus OCT (OCT3).
METHODS: Thirty-seven eyes from 37 healthy subjects underwent a complete ophthalmologic examination, including OCT. Six radial scans, 6 mm in length and centered on the fovea, were obtained using the OCT3. Retinal thickness was automatically calculated by OCT mapping software. Measurements were displayed as the mean and standard deviation for each of the 9 regions defined in the Early Treatment Diabetic Retinopathy Study.
RESULTS: Foveal thickness (mean thickness in the central 1000-microm diameter area) and central foveal thickness (mean thickness at the point of intersection of 6 radial scans) on the OCT3 were 212 +/- 20 and 182 +/- 23 microm, respectively. Macular thickness measurements were thinnest at the center of the fovea, thickest within 3-mm diameter of the center, and diminished toward the periphery of the macula. The temporal quadrant was thinner than the nasal quadrant. Central foveal thickness was also manually determined as 170 +/- 18 microm, approximately 12 microm less than the value automatically obtained from the OCT3 software. There was no correlation between age and foveal thickness (P = .80).
CONCLUSIONS: Mean foveal thickness measurements were 38 to 62 microm thicker than previously reported values, while mean central foveal thickness measurements were 20 to 49 microm thicker than previously published values. This discrepancy should be considered when interpreting OCT scans.

Entities:  

Mesh:

Year:  2006        PMID: 16476888      PMCID: PMC1941772          DOI: 10.1001/archopht.124.2.193

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  27 in total

1.  Intersession repeatability of macular thickness measurements with the Humphrey 2000 OCT.

Authors:  D Koozekanani; C Roberts; S E Katz; E E Herderick
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-05       Impact factor: 4.799

2.  Retinal thickness measurements with optical coherence tomography and the scanning retinal thickness analyzer.

Authors:  S Konno; J Akiba; A Yoshida
Journal:  Retina       Date:  2001       Impact factor: 4.256

3.  Comparison of foveal thickness measured with the retinal thickness analyzer and optical coherence tomography.

Authors:  A S Neubauer; S Priglinger; S Ullrich; M Bechmann; M J Thiel; M W Ulbig; A Kampik
Journal:  Retina       Date:  2001       Impact factor: 4.256

4.  [Retinal thickness and changes with age].

Authors:  Kaname Kanai; Tomoatsu Abe; Koichiro Murayama; Shin Yoneya
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2002-03

5.  Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT).

Authors:  Winfried Goebel; Tatjana Kretzchmar-Gross
Journal:  Retina       Date:  2002-12       Impact factor: 4.256

6.  Retinal thickness study with optical coherence tomography in patients with diabetes.

Authors:  Hortensia Sánchez-Tocino; Aurora Alvarez-Vidal; Miguel J Maldonado; Javier Moreno-Montañés; Alfredo García-Layana
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

7.  Reproducibility of retinal mapping using optical coherence tomography.

Authors:  P Massin; E Vicaut; B Haouchine; A Erginay; M Paques; A Gaudric
Journal:  Arch Ophthalmol       Date:  2001-08

8.  Repeatability and reproducibility of macular thickness measurements with the Humphrey OCT system.

Authors:  Sarah Muscat; Stuart Parks; Ewan Kemp; David Keating
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-02       Impact factor: 4.799

9.  Patterns of diabetic macular edema with optical coherence tomography.

Authors:  T Otani; S Kishi; Y Maruyama
Journal:  Am J Ophthalmol       Date:  1999-06       Impact factor: 5.258

10.  Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software.

Authors:  P Massin; A Erginay; B Haouchine; A Ben Mehidi; M Paques; A Gaudric
Journal:  Eur J Ophthalmol       Date:  2002 Mar-Apr       Impact factor: 2.597

View more
  106 in total

1.  Comparison of central macular thickness between two spectral-domain optical coherence tomography in elderly non-mydriatic eyes.

Authors:  Xiao-Gang Wang; Qing Peng; Qiang Wu
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

2.  Within-subject assessment of foveal avascular zone enlargement in different stages of diabetic retinopathy using en face OCT reflectance and OCT angiography.

Authors:  Giselle Lynch; Jorge S Andrade Romo; Rachel Linderman; Brian D Krawitz; Shelley Mo; Amir Zakik; Joseph Carroll; Richard B Rosen; Toco Y P Chui
Journal:  Biomed Opt Express       Date:  2018-11-05       Impact factor: 3.732

3.  Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration.

Authors:  Quan Dong Nguyen; Syed Mahmood Shah; Gulnar Hafiz; Diana V Do; Julia A Haller; Roberto Pili; Ingrid E Zimmer-Galler; Kashif Janjua; R C Andrew Symons; Peter A Campochiaro
Journal:  Am J Ophthalmol       Date:  2007-12-11       Impact factor: 5.258

4.  Macular thickness after uneventful cataract surgery determined by optical coherence tomography.

Authors:  Burkhard von Jagow; Christian Ohrloff; Thomas Kohnen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-10       Impact factor: 3.117

5.  Normative database of retinal nerve fiber layer and macular retinal thickness in a Thai population.

Authors:  Anita Manassakorn; Winai Chaidaroon; Somsanguan Ausayakhun; Soontaree Aupapong; Sopa Wattananikorn
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

6.  VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT).

Authors:  Stephanie A Hagstrom; Gui-shuang Ying; Gayle J T Pauer; Gwen M Sturgill-Short; Jiayan Huang; Maureen G Maguire; Daniel F Martin
Journal:  JAMA Ophthalmol       Date:  2014-05       Impact factor: 7.389

7.  Automatic detection of the foveal center in optical coherence tomography.

Authors:  Bart Liefers; Freerk G Venhuizen; Vivian Schreur; Bram van Ginneken; Carel Hoyng; Sascha Fauser; Thomas Theelen; Clara I Sánchez
Journal:  Biomed Opt Express       Date:  2017-10-23       Impact factor: 3.732

8.  Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness.

Authors:  Alan C Sull; Laurel N Vuong; Lori Lyn Price; Vivek J Srinivasan; Iwona Gorczynska; James G Fujimoto; Joel S Schuman; Jay S Duker
Journal:  Retina       Date:  2010-02       Impact factor: 4.256

9.  Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up (BERVOLT study: bevacizumab for RVO long-term follow-up).

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-14       Impact factor: 3.117

10.  High-speed, ultrahigh resolution optical coherence tomography of the retina in Hunter syndrome.

Authors:  Michael K Yoon; Royce W Chen; Thomas R Hedges; Vivek J Srinivasan; Iwona Gorczynska; James G Fujimoto; Maciej Wojtkowski; Joel S Schuman; Jay S Duker
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2007 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.